AVEO Oncology
AVEO
#7553
Rank
A$0.73 B
Marketcap
A$21.25
Share price
0.00%
Change (1 day)
149.97%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -A$40.76 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are A$94.31 Million. In 2021 the company made an earning of -A$75.56 Million a decrease over its 2020 earnings that were of -A$50.41 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -A$40.76 Million-46.06%
2021 -A$75.56 Million49.9%
2020 -A$50.41 Million-479.04%
2019 A$13.29 M-276.17%
2018 -A$7.55 Million-91.79%
2017 -A$91.97 Million142.38%
2016 -A$37.95 Million78.51%
2015 -A$21.26 Million-71.55%
2014 -A$74.71 Million-50.72%
2013 -A$0.16 Billion-4.88%
2012 -A$0.16 Billion-426.29%
2011 A$48.84 M-159.85%
2010 -A$81.63 Million35.33%
2009 -A$60.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
A$44.08 B-107,283.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.87 B-31,392.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.29 B-5,689.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$7.30 B-17,858.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.59 B-33,148.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-A$3.2 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA